Key result
Chronic inflammatory rheumatologic diseases are linked to accelerated atherosclerosis and increased CAD risk.
Answers are grounded in this paper and cite their sources.
Atherosclerosis is a complex inflammatory disease involving aberrant immune and tissue healing responses, which begins with endothelial dysfunction and ends with plaque development, instability and rupture. The increased risk for coronary artery disease in patients with rheumatologic diseases highlights how aberrancy in the innate and adaptive immune system may be central to development of both disease states and that atherosclerosis may be on a spectrum of immune-mediated conditions. Recognition of the tight association between chronic inflammatory disease and complications of atherosclerosis will impact the understanding of underlying pathogenic mechanisms and change diagnostic and therapeutic approaches in patients with rheumatologic syndromes as well as patients with coronary artery disease. In this review, we provide a summary of the role of the immune system in atherosclerosis, discuss the proposed mechanisms of accelerated atherosclerosis seen in association with rheumatologic diseases, evaluate the effect of immunosuppression on atherosclerosis and provide updates on available risk assessment tools, biomarkers and imaging modalities.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2015) conducted a review in Accelerated atherosclerosis in chronic inflammatory rheumatologic conditions. Chronic inflammatory rheumatologic disease and immunosuppression was evaluated. Chronic inflammatory rheumatologic conditions are associated with accelerated atherosclerosis and increased coronary artery disease risk via shared innate and adaptive immune mechanisms.
Synapse has enriched 10 related papers. Consider them for comparative context: